Class 4 medicine recallMedicine · 16 Oct 2019
Aventis Pharma Limited t/a Sanofi has informed the MHRA that a change to the Patient Information Leaflet concerning possible side effects for Rifadin (rifampicin) 150mg Capsules has not been implemented by the required timeline.
Class 4 medicine recallMedicine · 3 Oct 2019
The MHRA has notified Bausch and Lomb UK Limited of reports that Emerade pens have failed to activate. The MHRA is advising that Emerade devices should not be recalled.
Class 4 medicine recallMedicine · 11 Jul 2019
Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) has informed us of a risk of Emerade product failing to deliver a dose of adrenaline from the syringe due to blockage…
Class 4 medicine recallMedicine · 8 Jul 2019
Martindale Pharma has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that the EAN bar code for the following batches is incorrect.
Class 4 medicine recallMedicine · 3 Jun 2019
Baxter Healthcare Limited has informed us that a quality defect has been identified with the above product where the front panel of a small number of infusion bags was found to be missing the…
Class 4 medicine recallMedicine · 26 Apr 2019
Genesis Pharmaceuticals Ltd has informed us that there is an error on the Braille for the above batches which means that the strength reads as 1mg instead of 5mg. The printed text is correct…
Class 4 medicine recallMedicine · 24 Apr 2019
Pfizer Limited has informed us that the text on the carton label for the above product has recently been updated and at this time, the product description on the carton was changed from 10…
Class 4 medicine recallMedicine · 9 Apr 2019
Martindale Pharmaceuticals has informed us of two issues with all unexpired batches of the above product, PL 00156/0109, legal status ‘P’. The Braille is missing from the carton and the packs contain the Patient…
Class 4 medicine recallMedicine · 4 Apr 2019
Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed us that some packs from a batch of Zoledronic acid 5mg solution for infusion contain a Patient Information Leaflet for Temozolomide 180mg Capsules.
Class 4 medicine recallMedicine · 28 Feb 2019
Accord Healthcare Limited has informed us that there is an error on the portion of the Patient Information Leaflet (PIL) for the Paracetamol Infusion which is intended for Healthcare Professionals.
Class 4 medicine recallMedicine · 18 Feb 2019
Aguettant Limited has informed the MHRA that there is an error in the Patient Information Leaflet (PIL) for batches of Atropine Sulfate 3mg/10ml Solution for injection in pre-filled syringe.
Class 4 medicine recallMedicine · 4 Feb 2019
Accord Healthcare Limited has informed us that that a change to the Patient Information Leaflet (PIL) for this product has not been implemented by the required timeline.
Class 4 medicine recallMedicine · 18 Sep 2018
Cadiasun Pharma GmBH has informed us that there is an error on the patient information leaflet for Caspofungin 70mg powder for concentrate for solution for infusion.

Class 4 medicine recallMedicine · 3 Sep 2018
Daiichi Sankyo UK Limited has informed us that there is an error on the blister foil of specific batches of Olmetec 20mg Film-Coated Tablets
Class 4 medicine recallMedicine · 19 Jun 2018
Kyowa Kirin is advising caution in use for one lot of Bleo-Kyowa®, Powder for Solution for Injection, 15,000 IU following the detection of glass particles (EL (18) A/09)
Class 4 medicine recallMedicine · 18 Apr 2018
Caution in Use: Distribute to Pharmacy and Clinic Level.
Class 4 medicine recallMedicine · 24 Mar 2018
Mylan UK Healthcare Ltd has informed us that the GTIN barcode applied on the below batches is incorrect.
Class 4 medicine recallMedicine · 22 Feb 2018
Caution in Use - Distribute to Hospital Pharmacy, Ward, Chemotherapy Unit and Clinic Level. (EL (18) A/05)
Class 4 medicine recallMedicine · 19 Dec 2017
Caution in Use: Distribute to Hospital Pharmacy and Ward Level.
Class 4 medicine recallMedicine · 7 Dec 2017
Caution in Use: Distribute to Pharmacy, Hospital, GP, Dental Practice, Ward and Clinic Level.
Class 4 medicine recallMedicine · 13 Nov 2017
Caution in Use: Distribute to Hospital Pharmacy, Ward, Chemotherapy Unit and Clinic Level
Class 4 medicine recallMedicine · 17 Oct 2017
Caution in Use: Distribute to Hospital Pharmacy, Ward and Operating Theatre Level
Class 4 medicine recallMedicine · 5 Jan 2017
Bayer plc has informed us that they have received two complaints globally concerning Mirena inserters with an insertion tube which is mounted inversely to the handle
Class 4 medicine recallMedicine · 3 Jan 2017
Sanofi has informed us that there is an error in the Braille on some batches of Arava 10mg film-coated tablets (EL (17)A/01)